WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NATIONAL PHARMACEUTICAL COUNCIL INC, founded in 1953, is a mid-sized nonprofit that reported $10.9M in total revenue in fiscal year 2025. Revenue grew 16% year-over-year, indicating healthy expansion. Expenses of $12.6M exceeded revenue, resulting in a 15% operating deficit.
TO EXPLORE, DEMONSTRATE AND COMMUNICATE - THROUGH RESEARCH, PARTNERSHIP AND EDUCATION - THE ROLE AND VALUE OF INNOVATIVE BIOPHARMACEUTICALS TO ACHIEVE BETTER PATIENT HEALTH.
NPC FOCUSES ON RESEARCH DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. ALL ACTIVITIES...
NPC FOCUSES ON RESEARCH DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. ALL ACTIVITIES UNDERTAKEN BY NPC RELATED TO THESE FUNCTIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $10,925,821 | $9,421,713 | +0.2% |
| Expenses | $12,552,394 | $10,511,828 | +0.2% |
| Net Income | $-1,626,573 | $-1,090,115 | +0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JEN NORTON | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| REKHA RAMESH | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JUSTIN MCCARTHY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICK DUDEK | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PATTY FRITZ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KEVIN HERN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RUTH HOFFMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRIS LEIBMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TERRI STEWART | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TRENT MCLAUGHLIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RYAN MUNAFO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LANCE PIECORO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| COURTNEY PIRON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOHN O'BRIEN | PRESIDENT, CEO | 40.00 |
Officer
Director
|
$1,800,553 | $32,677 | $1,833,230 |
| KATE ROBINSON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRUCE WILSON | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| VALERIE REYNOLDS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SULABHA RAMACHANDRAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MIKE VALENTA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEVEN PIERI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINE MARSH | IMMEDIATE-PAST CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| KIMBERLY WESTRICH | CHIEF STRATEGY OFFICER | 40.00 |
Officer
|
$365,147 | $51,822 | $416,969 |
| JONATHAN CAMPBELL | CHIEF SCIENCE OFFICER | 40.00 |
Officer
|
$529,587 | $51,467 | $581,054 |
| MICHAEL PRATT | CHIEF COMMUNICATIONS OFFIC | 40.00 |
Officer
|
$379,511 | $44,333 | $423,844 |
| TANYA BAILEY | CHIEF OF STAFF | 40.00 |
Highest
|
$209,627 | $31,011 | $240,638 |
| KATHERINE LOVRO | SR. DIRECTOR ALLIANCE DEVELOPMENT | 40.00 |
Highest
|
$199,995 | $17,839 | $217,834 |
| JULIE PATTERSON | SENIOR DIRECTOR AND NPC EN | 40.00 |
Highest
|
$231,696 | $38,968 | $270,664 |
| KENNETH FINEGOLD | SR VP OF RESEARCH & POLICY | 40.00 |
Highest
|
$280,753 | $43,483 | $324,236 |
| JACQUELYN MCRAE | VP OF POLICY AND EXTERNAL AFFAIRS | 40.00 |
Highest
|
$228,946 | $11,475 | $240,421 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $10,925,821 | $12,552,394 | $23,057,598 | $-1,626,573 |
| 2024 | No data | No data | No data | No data |
| 2023 | $10,954,709 | $9,101,142 | $23,403,513 | $1,853,567 |
| 2022 | $8,284,643 | $10,099,912 | $24,620,287 | $-1,815,269 |
| 2021 | $11,522,521 | $10,209,029 | $24,820,917 | $1,313,492 |
| 2020 | $11,400,427 | $9,540,960 | $25,870,441 | $1,859,467 |
| 2019 | $10,894,667 | $8,311,767 | $19,560,800 | $2,582,900 |
| 2018 | $9,341,817 | $9,348,362 | $19,277,031 | $-6,545 |
Compare NATIONAL PHARMACEUTICAL COUNCIL INC with other nonprofits in District of Columbia and across the country.